All these recent mechanistic findings on TRPM8 provide new insights for the development of innovative and effective tools targeting TRPM8 to block PCa progression and improve the prognosis of the currently incurable metastatic castration-resistant prostate cancer (mCRPC) phenotypes. This evidence concerns the gene TRPM8 and posterior cortical atrophy.